First I've heard of it. But since I'm a skeptical pathology PhD student who works alongside a large group of SIV/HIV researchers I will say that this prospective preventative treatment does not offer 100% protection.
CCR5 is a receptor that HIV uses to dock and infect T-cells. Knocking down CCR5 is thought to prevent HIV from infecting human T cells because (1) it appears to work on Rhesus macaques (monkeys) and (2) people lacking CCR5 appear to be protected from HIV infection.
However other studies have already shown that HIV can use other cell surface proteins to dock and infect so the true impact of this kind of drug is up in the air. Additionally, the drugs that I read about maximally knock down CCR5 in T-cells by 90%. That still leaves plenty of T-cells out there expressing CCR5 at the T-cell surface.
Basically, it looks like these drugs could have a significant impact in slowing the spread of HIV, but not completely preventing it... and the question of whether such a drug will find its way to the hardest hit regions of the world (Africa, India, etc.) is an entirely different matter.